Nichola Rockliffe

Suggest Changes
Learn More
In chronic lymphocytic leukaemia (CLL), mutation/deletion of TP53 is strongly associated with early disease progression, resistance to chemotherapy and short patient survival. Consequently, there is(More)
  • 1